Page 444 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

418 Index

tryptophan, 94 vascular endothelial growth factor (VEGF), 98, 113,
tuberculosis, 17, 35, 36, 46, 57, 156, 164, 173, 251, 184

262, 382 vascular occlusion, 21, 199, 203, 344
tumor(s), 35, 47, 49, 57, 75, 93, 98, 110, 113, 115, vascular wall, 99, 168, 281
vascularization, 179, 376
165, 171, 183, 202, 251, 264, 282, 305, 324, 345, vasculature, 166, 203, 283, 342, 378
391, 397 vasoconstriction, 60, 167, 173
tumor growth, 265 vaso-occlusion, 353
tumor necrosis factor, 47, 57, 75, 93, 98, 110, 113, vasospasm, 209
115, 171, 202, 264, 282, 305, 324, 345, 397 VDRL, 36, 45, 46
Turkey, 81, 104, 111, 112, 118, 145, 265 vein, 27, 28, 36, 57, 119, 343, 344, 354, 362, 364,
twins, 307
type 1 diabetes, 105, 111 367, 376, 396
typhoid, 169 ventilation, 250
typhoid fever, 169 venules, 5, 6, 15, 16, 22, 23, 25, 33, 40, 121, 124,
tyrosine, 75, 97, 101, 109, 182, 185, 267
128, 129, 130, 131, 132, 134, 135, 136, 137, 141,
U 161, 178, 200, 229, 234, 288, 338, 343, 354, 371,
372, 376, 381, 385, 387, 389
ubiquitin, 101 vertebral artery, 280
ulcer, 296, 305, 381 vertigo, 7, 27, 180, 190, 356
ulcerative colitis, 105, 156, 390 vessel involvement, 17, 18, 30, 38, 40, 78, 142, 162,
ultrasonography, 45, 46, 168, 287, 311, 331, 335 208, 242, 277, 279, 281, 282, 290, 314, 320, 326,
ultrasound, 20, 312, 319 333, 344, 359, 371, 372, 374, 389, 393
uniform, ix, 6 vestibulocochlear nerve, 207
United Kingdom (UK), vii, 32, 62, 66, 67, 69, 70, viral infection, 86, 211, 227
virus infection, 10, 52, 55, 58, 122, 142, 199, 219,
71, 73, 76, 77, 79, 81, 85, 97, 101, 150, 152, 172, 227, 230, 239, 245, 283, 375
177, 189, 200, 262, 263, 267, 277, 299, 300, 311, virus replication, 214, 220
332, 346, 360, 363, 394 viruses, 45, 201, 229
United Nations (UN), 147, 201, 380 viscosity, 318
United States (USA), 5, 22, 24, 66, 69, 74, 83, 148, vision, 27, 212, 280, 317, 321, 322, 339, 341, 342,
261, 269, 272, 297 344, 345, 347, 348, 349, 350, 353, 354, 356, 357,
updating, 155 360, 388
upper airways, 242, 254 visual acuity, 36, 341, 342, 347, 357
upper respiratory tract, 134, 180, 181, 265, 286, 385 visual field, 341, 350, 357
urban, 68, 81, 220, 263, 271, 272, 361, 363 visualization, 122, 242
urban areas, 263 vitreous hemorrhage, 342
urinalysis, 21, 22, 149, 380, 385 voiding, 211
urine, 47, 213, 266, 268, 270, 275 vomiting, 18, 22, 27, 35, 37, 48, 167, 181, 356
urticaria, 136, 137, 181, 351, 369, 370, 381, 383,
389, 393, 397 W
UV, 26, 392
uveitis, 8, 27, 137, 179, 212, 289, 344, 345, 347, Wales, 77
348, 349, 350, 351, 352, 353, 354, 355, 356, 363, Washington, x
364, 366, 367, 372 weakness, 9, 28, 35, 38, 181, 201, 227, 230, 234,

V 283, 357, 380, 386
weight loss, 6, 18, 20, 22, 23, 32, 148, 162, 165, 179,
vaccinations, 312
vaccine, 163, 169, 201 205, 214, 216, 279, 282, 283, 284, 285, 288, 297,
validation, 76, 83 299, 301, 314, 316, 372, 374, 380, 386, 388
variations, 88, 96, 102, 104, 113, 238 Western Australia, 73
vascular diseases, 3, 9, 247 wheezing, 180, 242, 380
white blood cells, 46
white matter, 27, 38, 40, 206
wild type, 87, 188

Complimentary Contributor Copy